Overview

Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice

Status:
Unknown status
Trial end date:
2008-02-01
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of the study is to determine the effect of esomeprazole compared to placebo in patients from general practice who have previously been treated with proton-pump-inhibitors (PPI) and who have no upper endoscopic findings.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Treatments:
Esomeprazole
Proton Pump Inhibitors
Criteria
Inclusion Criteria:

- Treatment with PPI in at least 4 months out of the preceding 12.

- Use of PPI in the preceding 10 out of 30 days before inclusion

- Age above 18 years

Exclusion Criteria:

- Erosive Esophagitis

- PPI-treatment as prophylaxis against gastrointestinal bleeding

- PPI-treatment as prophylaxis against ulcers

- PPI-treatment as prophylaxis because of NSAID-treatment

- Pregnant or lactating women

- Previous upper GI surgery